Home

Catalyzing the regeneration of soft tissue to bone

PRO Therapeutics is an early-stage regenerative medicine company focused on the development and commercialization of a platform for soft tissue repair, allowing regeneration for tendons, ligaments, and muscles to restore native mechanical function.

THE PROBLEM

Costly rotator cuff tears currently have no reliable repair solution

< 0 %

of U.S. adults over 50 have rotator cuff tears

0 m+

annual cost to the U.S. health care system

0 k

Surgeries annually

26- 0 %

re-tear rate depending on severity and patient age

Age 0 +

largest demographic where risk to quality of life is high

Rotator cuff injuries are among the top sports injuries requiring over 400,000 surgeries costing the health care system over $523M annually. Depending on the severity of the tear and the age of the patient, re-tear rates range from 26-94%, making recovery and return to function challenging for many. Physical therapy can alleviate pain but not repair the damaged tendon. Patients over 60 represent the largest demographic where the risk of losing their quality of life and independence is high and costly.

THE SOLUTION

Catalyzing the regeneration of soft tissue to bone with PRO Therapeutics’ rotator cuff graft

  • Encourages the body’s own biological healing process and restores normal biomechanics when used to repair a tendon tear.
  • It provides an underlayment that allows migration of cells from bone to enhance the regenerative capacity of the tendon to the bone.
  • Will be provided as an off-the-shelf product
  • Expected minimal impact to current surgical procedures with significant reduction in or elimination of post-surgical re-tears that occur due to poor adhesion of tendon to bone

About PRO Therapeutics

PRO Therapeutics, LLC is an early-stage regenerative medicine company based in Manchester, NH focused on the development and commercialization of a platform for soft tissue repair, allowing regeneration for tendons, ligaments, and muscles to restore native mechanical function.

PRO Therapeutics is working in partnership with the Advanced Regenerative Manufacturing Institute (ARMI) as part of the inaugural cohort of the BioFab Startup Lab.

THE TEAM

ADVISORY BOARD

Julie Lenzer, MPS

Chief Executive Officer

Lisa Larkin, PhD

Chief Scientific Officer

ADVISORY BOARD

Tom Bollenbach, PhD

Richard McFarland M.D, PhD

Stephen Kennedy

Michael Orrico MBA, PhD

Publications and Documentation

The technology forming the foundation for PRO Therapeutics products is backed by a strong intellectual property portfolio and decades of research into soft tissue repair and tissue engineering. Example publications include:

Engineered Tissue Graft for Repair of Injured Infraspinatus Rotator Cuff Tendon

Tissue-Engineered Tendon Constructs for Rotator Cuff Repair in Sheep

Financial Conflict of Interest

GET IN TOUCH